CAXTON CORP 13F Portfolio
| Entity | Category | QoQ AUM Change | AUM (13F) | # of Holdings | Performance Rank | Equities Trend |
|---|---|---|---|---|---|---|
CC CAXTON CORP | Institutional Filer | ▼ 5.96% | $4.0M | 7 |
Current Portfolio Holdings
Showing all 7 reported positions by value
| # | Stock | Company Name | Sector | Shares Held | Market Value | % of Portfolio |
|---|---|---|---|---|---|---|
| 1 | GLD | SPDR GOLD TR | — | 8K | $3.3M | 81.50% |
| 2 | BRKB | BERKSHIRE HATHAWAY INC DEL | — | 727 | $348K | 8.66% |
| 3 | KYTX | Kyverna Therapeutics, Inc. | Healthcare | 19K | $162K | 4.03% |
| 4 | LXEO | Lexeo Therapeutics, Inc. Common Stock | Healthcare | 14K | $80K | 1.99% |
| 5 | XFOR | X4 Pharmaceuticals, Inc. | Healthcare | 16K | $64K | 1.60% |
| 6 | IKT | Inhibikase Therapeutics, Inc. | Healthcare | 28K | $48K | 1.19% |
| 7 | ALXO | ALX Oncology Holdings Inc. | Healthcare | 21K | $42K | 1.04% |
Showing 1 to 7 of 7 holdings